The Informed Genetics Annotated Patient Registry

Conditions

• Predisposition, Genetic

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Accepted

Study Details

This prospective and retrospective registry will evaluate the clinical effectiveness of Germline Genetic, Genomic, and other Biomarker testing results over time in different clinical populations, in order to shape guidelines for testing, patient management, and precision therapy.

Key Dates

Start date

Jan 23, 2019

Status verified

Apr 2022

Primary completion

Jan 1, 2025

Completion

Jan 1, 2030

Study Design

Enrollment

10,000 participants (estimated)

Arms

• Arm: Retrospective
  Inclusion criteria for Retrospective Subjects: * Men and women 18 years or older; * Is or was a patient of a Participating Practice and was previously tested with Germline, Genomic, or other Biomarker Tests; and * For Germline Genetic Test patients, have a diagnosis of cancer or pathogenic or likely pathogenic (P/LP) result.
• Arm: Prospective
  Inclusion criteria for Prospective Subjects: * Men and women aged 18 years or older; * Presents consecutively to a Participating Practice and who has previously been screened and tested (i.e., is a new patient scheduled for a visit at a Participating Practice or is an existing patient who returns to a Participating Practice); * Receives or has received Germline, Genomic, or other Biomarker Testing, either through a prior healthcare provider or a Participating Practice; and * Consents to be a part of the Registry.

Primary Outcome Measure

To understand the utilization of Germline Genetic, Genomic, and Biomarker Testing in various clinical settings. [ Time Frame: 10 years ]

Locations (5)

Find similar trials in Redding, CA

Related Studies

• Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study
  Recruiting · Dana-Farber Cancer Institute · Boston, Massachusetts